JP2008526789A - タウリンの合成、生成及び医薬としての利用 - Google Patents

タウリンの合成、生成及び医薬としての利用 Download PDF

Info

Publication number
JP2008526789A
JP2008526789A JP2007549796A JP2007549796A JP2008526789A JP 2008526789 A JP2008526789 A JP 2008526789A JP 2007549796 A JP2007549796 A JP 2007549796A JP 2007549796 A JP2007549796 A JP 2007549796A JP 2008526789 A JP2008526789 A JP 2008526789A
Authority
JP
Japan
Prior art keywords
effective
concentrations
combinations
taurine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007549796A
Other languages
English (en)
Japanese (ja)
Inventor
アーメッド コトブ アブダラ，マグド
Original Assignee
アーメッド コトブ アブダラ，マグド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アーメッド コトブ アブダラ，マグド filed Critical アーメッド コトブ アブダラ，マグド
Publication of JP2008526789A publication Critical patent/JP2008526789A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007549796A 2005-01-05 2005-12-31 タウリンの合成、生成及び医薬としての利用 Pending JP2008526789A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EG2005010013 2005-01-05
PCT/EG2005/000044 WO2006072259A2 (en) 2005-01-05 2005-12-31 Taurine synthesis, production and utility as a medicine

Publications (1)

Publication Number Publication Date
JP2008526789A true JP2008526789A (ja) 2008-07-24

Family

ID=36647837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007549796A Pending JP2008526789A (ja) 2005-01-05 2005-12-31 タウリンの合成、生成及び医薬としての利用

Country Status (15)

Country Link
EP (1) EP1844006A2 (ko)
JP (1) JP2008526789A (ko)
KR (1) KR20070091198A (ko)
CN (1) CN101146767A (ko)
AP (1) AP2007004084A0 (ko)
AU (1) AU2005324199A1 (ko)
BR (1) BRPI0519606A2 (ko)
CA (1) CA2593563A1 (ko)
EA (1) EA200701434A1 (ko)
IL (1) IL184221A0 (ko)
MA (1) MA29238B1 (ko)
MX (1) MX2007008196A (ko)
NO (1) NO20074937A (ko)
TN (1) TNSN07226A1 (ko)
WO (1) WO2006072259A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100091219A (ko) 2007-11-30 2010-08-18 더 리전트 오브 더 유니버시티 오브 캘리포니아 시스테아민 산물을 이용한 비-알코올성 지방성간염(ｎａｓｈ) 치료 방법
CN103382170B (zh) * 2012-10-25 2015-04-08 潜江永安药业股份有限公司 一种牛磺酸的制备方法
CN106728405A (zh) * 2016-11-15 2017-05-31 陈思文 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140017A (ja) * 1981-12-22 1983-08-19 Junichi Azuma 心不全治療剤
JPH08208464A (ja) * 1994-12-02 1996-08-13 Taisho Pharmaceut Co Ltd 高脂血症の治療及び予防薬
JPH11199477A (ja) * 1997-10-24 1999-07-27 Pharma Nord Uk Ltd 肝臓疾患のための医薬処方
JP2000508331A (ja) * 1996-04-12 2000-07-04 ホイジンガー，デイーター 感染、炎症または免疫障害の影響を治療するためのオスモライトの使用
JP2002535364A (ja) * 1999-01-29 2002-10-22 マーズ ユー ケー リミテッド ペット用動物のための抗酸化剤組成物およびその使用方法
JP2003526624A (ja) * 1999-04-20 2003-09-09 サヴィファーム インコーポレイテッド 肝臓病の予防及び治療に有用なアミノイミダゾールカルボキサミド塩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026642A2 (en) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
CN1340502A (zh) * 2000-06-30 2002-03-20 张永春 牛磺酸合锌的生产工艺
CN1268733C (zh) * 2004-07-20 2006-08-09 刘辉 牛磺酸功能啤酒及其生产工艺

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140017A (ja) * 1981-12-22 1983-08-19 Junichi Azuma 心不全治療剤
JPH08208464A (ja) * 1994-12-02 1996-08-13 Taisho Pharmaceut Co Ltd 高脂血症の治療及び予防薬
JP2000508331A (ja) * 1996-04-12 2000-07-04 ホイジンガー，デイーター 感染、炎症または免疫障害の影響を治療するためのオスモライトの使用
JPH11199477A (ja) * 1997-10-24 1999-07-27 Pharma Nord Uk Ltd 肝臓疾患のための医薬処方
JP2002535364A (ja) * 1999-01-29 2002-10-22 マーズ ユー ケー リミテッド ペット用動物のための抗酸化剤組成物およびその使用方法
JP2003526624A (ja) * 1999-04-20 2003-09-09 サヴィファーム インコーポレイテッド 肝臓病の予防及び治療に有用なアミノイミダゾールカルボキサミド塩

Also Published As

Publication number Publication date
MX2007008196A (es) 2008-02-22
TNSN07226A1 (en) 2008-11-21
IL184221A0 (en) 2008-12-29
AP2007004084A0 (en) 2007-08-31
CN101146767A (zh) 2008-03-19
WO2006072259A2 (en) 2006-07-13
MA29238B1 (fr) 2008-02-01
WO2006072259A3 (en) 2007-10-04
EP1844006A2 (en) 2007-10-17
CA2593563A1 (en) 2006-07-13
KR20070091198A (ko) 2007-09-07
EA200701434A1 (ru) 2008-10-30
NO20074937A (no) 2007-09-28
AU2005324199A1 (en) 2006-07-13
BRPI0519606A2 (pt) 2009-02-25

Similar Documents

Publication Publication Date Title
JP7457401B2 (ja) 毒性アルデヒド関連疾患および処置
JP4555263B2 (ja) カルシウムチャンネルα２δサブユニットに親和性を有するプロリン誘導体
AU2006242914B2 (en) New DHA derivatives and their use as medicaments
DK2041068T3 (en) POSITIVELY CHARGED, WATER SOLUBLE PRODRUGS OF IBUPROFEN WITH VERY FAST SKIN PENETRATION SPEED
CA2695664C (en) Phenoxy-pyrrolidine derivative and its use and compositions
EP1784388B8 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
JP2012520344A (ja) 多価不飽和脂肪酸ヒドロキシ誘導体及びその薬物としての使用
JP2022510691A (ja) 線維症及び炎症の処置のための組成物
WO2019113210A1 (en) Phosphonium-based ionic drug conjugates
JP5671483B2 (ja) 色素沈着予防又は改善剤
JP2008526789A (ja) タウリンの合成、生成及び医薬としての利用
JP6577951B2 (ja) 新規ｃｙｐ−エイコサノイド誘導体
CN101166524A (zh) 氨基酸衍生物
EP2607366A1 (en) Glycerol phenyl butyrate esters
WO2007134038A3 (en) Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
IL226672A (en) Prodrug compounds for vodopa, preparations containing them and their uses
JP2015533114A (ja) 神経疾患の治療のための組成物及び方法
US20190216752A1 (en) Pharmaceutical composition for preventing or treating degenerative brain disease
US20130225545A1 (en) Porphyrin treatment of neurodegenerative diseases
US20130131361A1 (en) Novel medical application of lipid derivatives of dopamine and the methods of their production
CA2494546A1 (en) Substituted glycine derivatives for use as medicaments
PT87732B (pt) Processo para a preparacao da (e)-2-(p-fluorofenetil)-3-fluoroalilamina
TW202237073A (zh) 官能化長鏈烴單羧酸及二羧酸及其衍生物以及其於預防或治療疾病之用途
JP2015514728A5 (ko)
JP2006507238A (ja) アリールアミノ酸誘導体の治療的使用

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110315

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110614

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110621

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111101